• Mashup Score: 0
    VJOncology – The video journal of oncology - 1 year(s) ago

    The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology

    Source: VJOncology
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJOncology
      VJOncology

      Miss out on #ESMOImmuno22? Catch up by heading to https://t.co/ys1d8pDAKO for on-demand sessions with leading experts in #ImmunoOnc! @myESMO #CellTherapy #Oncology #immunotherapy https://t.co/QGBLBxTeiz

  • Mashup Score: 3
    cAttendee - 1 year(s) ago

    Source: cattendee.abstractsonline.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of myESMO
      myESMO

      Don't forget that all sessions from #ESMOImmuno22 are available on-demand on the virtual platform until 12 December 2022 at 12:00 CET for all registered participants - so if you missed a great scientific or educational session head over here 👇 https://t.co/cQHZtVU6iM https://t.co/DWdj4Yj199

  • Mashup Score: 3
    VJOncology – The video journal of oncology - 1 year(s) ago

    The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology

    Source: VJOncology
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJOncology
      VJOncology

      That’s a wrap on #ESMOImmuno22! 🎉 Well done to all the speakers, and to catch up on the latest in #ImmunoOnc, head to https://t.co/ys1d8pDAKO! @myESMO #CellTherapy #Oncology #immunotherapy https://t.co/6vyEWW0OW7

  • Mashup Score: 2
    Do immune checkpoint inhibitors affect COVID-19 severity? - 1 year(s) ago

    A joint analysis confirms the protective role of anti-SARS-CoV-2 vaccination in cancer patients treated with immunotherapy

    Source: Daily Reporter
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of myESMO
      myESMO

      #ESMOImmuno22: Do immune checkpoint inhibitors affect COVID-19 severity? A joint analysis of the OnCovid and ESMO CoCARE registries confirms the protective role of anti-Sars-CoV-2 vaccination in cancer patients treated with #Immunotherapy 👉https://t.co/SavyzONJqW https://t.co/mzQf174mFW

  • Mashup Score: 1
    ESMO Immuno-Oncology Congress 2022 - 1 year(s) ago

    The ESMO Immuno-Oncology Congress will take place as an onsite event in Geneva, Switzerland, 7-9 December 2022, as well as online

    Source: www.esmo.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MarcoGerlinger
      MarcoGerlinger

      RT @BartsGI_Cancer: End of year wrap up of immunotherapy progress in GI cancer at #ESMOImmuno22 congress today https://t.co/nwiEL2ZKte. Cha…

  • Mashup Score: 0
    VJOncology – The video journal of oncology - 1 year(s) ago

    The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology

    Source: VJOncology
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJOncology
      VJOncology

      💥The final day of #ESMOImmuno22 and it’s been great to hear from leading experts discuss practice-changing updates in #ImmunoOnc! Don’t forget to visit https://t.co/ys1d8pDAKO to see this year’s highlights! @myESMO #CellTherapy #Oncology #immunotherapy https://t.co/U7yurBWzHx

  • Mashup Score: 1
    Combined biomarker analysis shows promise in solid tumours - 1 year(s) ago

    Pre-treatment expression of Ki-67 plus FOXC1 plus PD-L1 predicted response to neoadjuvant treatment in breast and head and neck tumours

    Source: Daily Reporter
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of myESMO
      myESMO

      #ESMOImmuno22: Pre-treatment expression of Ki-67 plus FOXC1 plus PD-L1 predicted response to neoadjuvant treatment in #Breast and #HeadandNeck tumours, although more work is required to determine its use in the context of immunotherapy alone. 👉https://t.co/7ob0KxfnyA https://t.co/ld9eGZGhER

Load More